Literature DB >> 1373797

Regulation and subcellular location of nitrogen oxide synthases in RAW264.7 macrophages.

H H Schmidt1, T D Warner, M Nakane, U Förstermann, F Murad.   

Abstract

In nitrinergic signal transduction, nitrogen oxide (NO) synthases (NOS) (EC 1.14.23) catalyze the conversion of L-arginine to L-citrulline and NO, which in turn activates soluble guanylyl cyclase. Macrophages were reported to contain a single isoform of NOS (type II, soluble, Ca(2+)-independent, 130-kDa) and only upon activation of the cells by interferon-gamma (INF) and lipopolysaccharides (LPS). By a mechanism involving L-type Ca2+ channels, calmodulin, and serine proteases, INF/LPS also induce a cytotoxic activation of macrophages. In RAW264.7 macrophages, NO release was detected upon activation of the cells by INF/LPS but also, although at a 20-fold lower level, in control cells. The latter constitutive NOS activity and NO release were Ca2+ dependent and were decreased in INF/LPS-activated RAW264.7 cells or with increasing passage number. RAW264.7 cells did not express soluble guanylyl cyclase, suggesting other target molecules for NO. In INF/LPS-activated cells, NOS activities and NO release were Ca2+ independent (type II) and coinduced with NADPH-diaphorase activities both in the soluble and in the particulate fractions. The NOS-II activities corresponded to a 130-kDa protein, by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, which was not recognized in a protein immunoblot with anti-NOS-I antibody. The serine protease inhibitor tosyl-lysyl chloromethyl ketone abolished the induction of NOS-II by INF/LPS, by depleting intracellular thiol pools and interfering with protein synthesis. Induction of NOS-II by INF/LPS was transcriptionally based and, for maximal enzyme activity, required increased intracellular tetrahydrobiopterin levels, intracellular Ca2+ mobilization, and activation of non-L-type Ca2+ channels but, unlike the induction of macrophage-mediated cytotoxicity, neither L-type-Ca2+ channels nor calmodulin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1373797

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  58 in total

1.  Stimulation of unprimed macrophages with immune complexes triggers a low output of nitric oxide by calcium-dependent neuronal nitric-oxide synthase.

Authors:  Zhi Huang; Fukun W Hoffmann; Jeffrey D Fay; Ann C Hashimoto; Moti L Chapagain; Pakieli H Kaufusi; Peter R Hoffmann
Journal:  J Biol Chem       Date:  2011-12-28       Impact factor: 5.157

2.  C331A mutant of neuronal nitric-oxide synthase is labilized for Hsp70/CHIP (C terminus of HSC70-interacting protein)-dependent ubiquitination.

Authors:  Kelly M Clapp; Hwei-Ming Peng; Yoshihiro Morishima; Miranda Lau; Vyvyca J Walker; William B Pratt; Yoichi Osawa
Journal:  J Biol Chem       Date:  2010-08-20       Impact factor: 5.157

3.  Characterization of NR10(2) macrophages.

Authors:  J G Bruno; J E Parker; J Kalns; T J Darcy; T R Grubbs; A B Cox; P J Morales; J L Alls; J L Kiel
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-09       Impact factor: 2.416

4.  Nitric oxide mediates relative airway hyporesponsiveness to lipopolysaccharide in surfactant protein A-deficient mice.

Authors:  Amy M Pastva; Julia K L Walker; Lee A Maddox; Sambuddho Mukherjee; Charles Giamberardino; Bethany Hsia; Erin Potts; Hongmei Zhu; Simone Degan; Mary E Sunday; Barbara L Lawson; Thomas R Korfhagen; David A Schwartz; Jerry P Eu; William M Foster; Timothy J McMahon; Loretta Que; Jo Rae Wright
Journal:  Am J Respir Cell Mol Biol       Date:  2010-03-26       Impact factor: 6.914

5.  Nitrite, nitrate and cGMP in the cerebrospinal fluid in degenerative neurologic diseases.

Authors:  M Ikeda; I Sato; T Yuasa; T Miyatake; S Murota
Journal:  J Neural Transm Gen Sect       Date:  1995

6.  Bacterial infection induces nitric oxide synthase in human neutrophils.

Authors:  M A Wheeler; S D Smith; G García-Cardeña; C F Nathan; R M Weiss; W C Sessa
Journal:  J Clin Invest       Date:  1997-01-01       Impact factor: 14.808

7.  Nitric oxide-mediated inactivation of mammalian ferrochelatase in vivo and in vitro: possible involvement of the iron-sulphur cluster of the enzyme.

Authors:  T Furukawa; H Kohno; R Tokunaga; S Taketani
Journal:  Biochem J       Date:  1995-09-01       Impact factor: 3.857

8.  Nitric oxide decreases expression of osmoprotective genes via direct inhibition of TonEBP transcriptional activity.

Authors:  Wolfgang Neuhofer; Maria-Luisa Fraek; Franz-X Beck
Journal:  Pflugers Arch       Date:  2008-06-21       Impact factor: 3.657

9.  Diallyl sulfide protects against N-nitrosodiethylamine-induced liver tumorigenesis: role of aldose reductase.

Authors:  Safinaz-S Ibrahim; Noha-N Nassar
Journal:  World J Gastroenterol       Date:  2008-10-28       Impact factor: 5.742

10.  Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants.

Authors:  O G Khatsenko; S S Gross; A B Rifkind; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.